The PennZone

  • Home
  • Business
  • Health
  • Non-profit
  • Technology
  • Services
  • Music
  • Travel
  • Construction

DG Meditech Opens Doors to North American Operations With Appointment of New Chief for Americas
The PennZone/10148921

Trending...
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
DGMeditech
TRAVERSE CITY, Mich. & TORONTO - PennZone -- The DG Meditech today announced the appointment of Davis Gravelsins as Chief Executive Officer, US Operations. Previously working as Senior Liaison Digital Transition - Healthcare on projects in the Baltic and in the E.U., Mr. Gravelsins will now be heading up DG Meditech's service expansion into North and South American geographies.

Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.

Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.

More on The PennZone
  • Harry Hayman Celebrates Years of WHYY Coverage, Partnership & Shared Commitment to Philadelphia
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Stockwell Elastomerics expands micro molding capabilities
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026

Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.

The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.

"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.

-        30  –

For more information, please contact us:

Toronto, Canada Office: Mr. D. Gravelsins

davis.gravelsins@dgmeditech.com

Travers City Office: Mr. J. Anson

janson@dgmeditech.com – 705-943-8225

Contact
Davis Gravelsins
***@dgmeditech.com


Source: DGMeditech

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Top Tips for Hiring HVAC Contractors in Philadelphia
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • Virtual Pizza Academy Announces the Return of Two Acclaimed Live Classes in 2026:
  • Teresa James & The Rhythm Tramps announce their new album and debut on MoMojo Records, 'Bad at Being Good'
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Beycome Closes $2.5M Seed Round Led by InsurTech Fund
  • VIP Vacations Invited to Travel Weekly's Annual Readers Choice Awards
  • Tru by Hilton Columbia South Opens to Guests
  • Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
  • "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
  • Harry Hayman IV & Gemini Consultants Announce Holiday Toys‑for‑Tots Giveaway with Retired Sixers
  • 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 1164
  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 113
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
  • Escajeda Masonry & Concrete Among Pittsburgh's Fastest-Growing Companies
  • VIP Vacations Wins Diamon Status with AIC Hotel Group
  • Eagles LB Jihaad Campbell Brings Surprise Visit for Together We Dance Foundation
  • Stoxtel Introduces High-Throughput "Matrix" Engine to Address Mexico's Crypto Trading Volatility

Similar on PennZone

  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Artificial Intelligence Leader Releases Children's Book on Veterans Day
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us